MedKoo Cat#: 597710 | Name: Pbc 264

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pbc 264 is a CCK agonist.

Chemical Structure

Pbc 264
Pbc 264
CAS#125236-85-3

Theoretical Analysis

MedKoo Cat#: 597710

Name: Pbc 264

CAS#: 125236-85-3

Chemical Formula: C51H62T5N9O14S

Exact Mass: 1071.4939

Molecular Weight: 1072.24

Elemental Analysis: C, 57.13; H, 7.23; N, 11.76; O, 20.89; S, 2.99

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Pbc 264; Pbc-264; Pbc264;
IUPAC/Chemical Name
(5S,8S,14S,17S,20S)-14-((1H-indol-3-yl)methyl)-20-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-8,17-dibutyl-16-methyl-3,6,11,12,15,18-hexaoxo-5-(4-(sulfooxy)benzyl)-4,7,9,13,16,19-hexaazadocosan-22-oic-1,1,1,2,2-t5 acid
InChi Key
FUSWTGJFWWZELH-LWSGDBLMSA-N
InChi Code
InChI=1S/C51H67N9O14S/c1-5-8-19-41(49(68)57-39(28-45(63)64)47(66)56-37(46(52)65)25-31-15-11-10-12-16-31)60(4)51(70)40(27-33-29-53-36-18-14-13-17-35(33)36)58-50(69)42(61)30-54-43(20-9-6-2)59-48(67)38(55-44(62)7-3)26-32-21-23-34(24-22-32)74-75(71,72)73/h10-18,21-24,29,37-41,43,53-54H,5-9,19-20,25-28,30H2,1-4H3,(H2,52,65)(H,55,62)(H,56,66)(H,57,68)(H,58,69)(H,59,67)(H,63,64)(H,71,72,73)/t37-,38-,39-,40-,41-,43-/m0/s1/i3T3,7T2
SMILES Code
O=C(N)[C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC([C@H](CCCC)N(C([C@H](CC2=CNC3=C2C=CC=C3)NC(C(CN[C@@H](NC([C@@H](NC(C([3H])([3H])C([3H])([3H])[3H])=O)CC4=CC=C(OS(=O)(O)=O)C=C4)=O)CCCC)=O)=O)=O)C)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,072.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Durieux C, Ruiz-Gayo M, Roques BP. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264. Eur J Pharmacol. 1991 Dec 17;209(3):185-93. PubMed PMID: 1797561. 2: Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Mol Pharmacol. 1992 Jun;41(6):1089-95. PubMed PMID: 1614411. 3: Durieux C, Corringer PJ, Bergeron F, Roques BP. [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors. Eur J Pharmacol. 1989 Sep 13;168(2):269-70. PubMed PMID: 2606153. 4: Ruiz-Gayo M, Durieux C, Fournié-Zaluski MC, Roques BP. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins. J Neurochem. 1992 Nov;59(5):1805-11. PubMed PMID: 1357099. 5: Blanco-Príeto MJ, Leo E, Delie F, Gulik A, Couvreur P, Fattal E. Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method. Pharm Res. 1996 Jul;13(7):1127-9. PubMed PMID: 8842057. 6: Taghzouti K, Léna I, Dellu F, Roques BP, Daugé V, Simon H. Cognitive enhancing effects in young and old rats of pBC264, a selective CCK(B) receptor agonist. Psychopharmacology (Berl). 1999 Apr;143(2):141-9. PubMed PMID: 10326776.